Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Phase 3 Completed
1,895 enrolled 16 charts
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
838 enrolled
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
1,076 enrolled
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
600 enrolled 16 charts
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Phase 3 Completed
6,136 enrolled
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Phase 3 Completed
205 enrolled 19 charts
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
5,377 enrolled 18 charts
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Phase 3 Completed
3,154 enrolled 26 charts
Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Phase 3 Completed
166 enrolled 18 charts
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
Phase 3 Completed
393 enrolled 17 charts
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
1,970 enrolled
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
3,054 enrolled
AIEOP LLA 2000
Phase 3 Completed
2,039 enrolled
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
276 enrolled
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 3 Completed
2,000 enrolled
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
Phase 3 Completed
428 enrolled
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Phase 3 Completed
2,078 enrolled
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Phase 3 Completed
120 enrolled
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Phase 3 Completed
254 enrolled
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
4,559 enrolled
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase 3 Completed
880 enrolled
Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia
Phase 3 Completed
394 enrolled
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 3 Completed